325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629846974627840 |
|---|---|
| author | Mark Cobbold Gordon Moody Kelly McGlinchey Emily Bosco Peter Zanvit Christine Fazenbaker Weichuan Luo Jessica Pezold Clare Hoover |
| author_facet | Mark Cobbold Gordon Moody Kelly McGlinchey Emily Bosco Peter Zanvit Christine Fazenbaker Weichuan Luo Jessica Pezold Clare Hoover |
| author_sort | Mark Cobbold |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:59:40Z |
| format | Article |
| id | doaj.art-e5e673da0a984d5aafd7bab7e39bcc6a |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:59:40Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-e5e673da0a984d5aafd7bab7e39bcc6a2023-11-12T21:05:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0325325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX modelsMark Cobbold0Gordon Moody1Kelly McGlinchey2Emily Bosco3Peter Zanvit4Christine Fazenbaker5Weichuan Luo6Jessica Pezold7Clare Hoover8Aff293 grid.32224.350000000403869924Massachusetts General Hospital Cancer Center Boston MA USA1AstraZeneca, Gaithersburg, MD, USAAff3 grid.418152.bDepartment of OncologyMedImmune One Medimmune Way 20878 Gaithersburg MD USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA2AstraZeneca, Cambridge, UK |
| spellingShingle | Mark Cobbold Gordon Moody Kelly McGlinchey Emily Bosco Peter Zanvit Christine Fazenbaker Weichuan Luo Jessica Pezold Clare Hoover 325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models Journal for ImmunoTherapy of Cancer |
| title | 325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models |
| title_full | 325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models |
| title_fullStr | 325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models |
| title_full_unstemmed | 325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models |
| title_short | 325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models |
| title_sort | 325 armored steap2 car t azd0754 alone and in combination with enzalutamide demonstrates anti tumor activity across a range of steap2 expressing prostate cancer pdx models |
| work_keys_str_mv | AT markcobbold 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT gordonmoody 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT kellymcglinchey 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT emilybosco 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT peterzanvit 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT christinefazenbaker 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT weichuanluo 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT jessicapezold 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels AT clarehoover 325armoredsteap2cartazd0754aloneandincombinationwithenzalutamidedemonstratesantitumoractivityacrossarangeofsteap2expressingprostatecancerpdxmodels |